Contrave vs Ozempic: Which Weight Loss Medication Is Right for You?

Choosing between weight loss medications can feel overwhelming, especially when options work through entirely different mechanisms. Contrave and Ozempic represent two distinct approaches to treating obesity: Contrave targets the brain’s reward pathways to reduce cravings and emotional eating, while Ozempic works through gut hormone signaling to suppress appetite and enhance satiety. Understanding these differences helps you identify which medication aligns with your specific challenges.

The effectiveness gap is significant. Ozempic (semaglutide) produces approximately 15% average body weight loss, while Contrave produces 5-8%. For someone weighing 220 pounds, that’s the difference between losing roughly 33 pounds versus 11-18 pounds. By raw weight loss numbers, semaglutide is clearly more effective.

But weight loss medications aren’t one-size-fits-all. Contrave may be particularly helpful for people whose eating is driven by cravings, emotional triggers, or food reward-seeking behavior. Some patients prefer oral medication over injections. Others have contraindications to one medication but not the other. And cost differences may influence accessibility.

This guide provides a comprehensive comparison to help you understand which medication might work better for your specific situation.

This guide covers:

• How each medication works (completely different mechanisms)
• Weight loss effectiveness: what the research shows
• Side effect profiles and tolerability
• Who each medication helps most (different eating patterns)
• Cardiovascular considerations
• Cost and insurance comparison
• Contraindications and safety concerns
• Practical aspects of taking each medication
• How to decide between them

Key Takeaways

• Ozempic produces significantly greater weight loss (15% average) compared to Contrave (5-8% average)
• Different mechanisms: Contrave targets reward pathways and cravings; semaglutide works through GLP-1 appetite signaling
• Contrave may help with emotional eating and food cravings more specifically than semaglutide
• Administration differs: Contrave is twice-daily oral pills; semaglutide is a weekly injection
• Side effects differ: Contrave causes CNS effects (headache, insomnia, dry mouth); semaglutide causes GI effects (nausea, diarrhea)
• Cardiovascular profiles differ: Semaglutide provides protection; Contrave may modestly increase blood pressure/heart rate
• Contrave has more contraindications, including seizure disorders, eating disorders, and opioid use
• Neither is a controlled substance, unlike phentermine
• Contrave costs less ($100-300/month vs $199-349/month for semaglutide)
• Both are FDA-approved for weight loss, though through different formulations

How Each Medication Works

Understanding the mechanisms explains why these medications produce different effects and suit different patients.

Contrave’s Mechanism

Contrave combines two medications: naltrexone (an opioid antagonist) and bupropion (an antidepressant). This combination targets the brain’s reward and appetite systems:

Bupropion component:

• Acts on dopamine and norepinephrine pathways in the brain
• Originally developed as an antidepressant (Wellbutrin) and smoking cessation aid (Zyban)
• Reduces appetite through hypothalamic effects
• May increase energy expenditure modestly
• Affects reward pathways that influence food-seeking behavior

Naltrexone component:

• Blocks opioid receptors in the brain
• Originally used for alcohol and opioid addiction treatment
• Reduces the rewarding aspects of eating
• May blunt the pleasure response to highly palatable foods
• Enhances bupropion’s appetite effects when combined

Combined effect: The medications work synergistically. Bupropion activates neurons that reduce appetite, while naltrexone blocks inhibitory feedback that would otherwise limit this effect. Together, they reduce hunger while also diminishing the reward and pleasure derived from eating, potentially helping people who struggle with cravings and emotional eating.

What this means practically: Contrave may help reduce the pull toward comfort foods, decrease preoccupation with food, and make it easier to resist cravings. The effect is more about reducing the reward value of food than producing the profound fullness that GLP-1 medications create.

Semaglutide’s Mechanism

Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist that works through gut hormone pathways:

GLP-1 receptor activation:

• Mimics the natural gut hormone GLP-1, which is released after eating
• Acts on brain appetite centers to produce genuine hunger reduction
• Creates feelings of satiety and fullness that persist between meals

Gastric effects:

• Slows gastric emptying, keeping food in the stomach longer
• Prolongs feelings of fullness after meals
• Reduces the volume of food needed to feel satisfied

Metabolic effects:

• Improves insulin sensitivity
• Enhances glucose-dependent insulin secretion
• Reduces glucagon release

What this means practically: Semaglutide makes you feel genuinely less hungry and more easily satisfied. Patients often describe it as quieting the “food noise” in their heads. The appetite reduction is substantial and sustained, naturally leading to eating less without constant willpower exertion.

Comparing the Mechanisms

Aspect	Contrave	Semaglutide
Primary target	Brain reward pathways	GLP-1 appetite pathways
Main effect	Reduces cravings/reward from food	Reduces hunger, increases satiety
How it feels	Less pull toward food	Less hungry, fuller faster
Metabolic effects	Minimal	Significant (glucose, insulin)
Emotional eating	May specifically help	Helps indirectly through appetite
Administration	Oral, twice daily	Injection, once weekly

Why the Mechanism Difference Matters

The different mechanisms mean these medications may suit different eating patterns:

Contrave may work better for:

• Emotional eaters who turn to food for comfort
• People who experience strong cravings for specific foods
• Those who struggle with the rewarding aspects of eating
• People whose eating is driven more by pleasure-seeking than true hunger

Semaglutide may work better for:

• People with persistent, generalized hunger
• Those who struggle with portion control and feeling full
• People who graze or eat frequently due to not feeling satisfied
• Those who would benefit from metabolic improvements alongside weight loss

In practice, most people’s eating involves multiple factors, and both medications produce weight loss across different eating patterns. But understanding the mechanisms helps explain why some patients respond better to one versus the other.

Weight Loss Effectiveness

The clinical data shows a clear difference in weight loss magnitude between these medications.

Contrave Weight Loss Results

Contrave produces moderate weight loss:

COR (Contrave Obesity Research) trials:

• COR-I trial: 6.1% average weight loss at 56 weeks (vs. 1.3% placebo)
• COR-II trial: 6.4% average weight loss at 56 weeks
• COR-BMOD trial (with intensive behavioral therapy): 9.3% average weight loss

Distribution of results:

• Approximately 50% of patients lose at least 5% of body weight
• Approximately 25-30% lose at least 10%
• Fewer than 15% achieve 15% or greater loss

What this means practically: For someone weighing 220 pounds:

• Average result: 13-14 pounds lost (reaching 206-207 pounds)
• Good responder: 22 pounds lost (reaching 198 pounds)
• Excellent responder: 33 pounds lost (reaching 187 pounds), but uncommon

Semaglutide Weight Loss Results

Semaglutide produces substantially greater weight loss:

STEP trials (semaglutide 2.4mg):

• STEP 1: 14.9% average weight loss at 68 weeks (vs. 2.4% placebo)
• 86% of participants lost at least 5%
• 69% lost at least 10%
• 50% lost at least 15%
• 32% lost at least 20%

What this means practically: For someone weighing 220 pounds:

• Average result: 33 pounds lost (reaching 187 pounds)
• Good responder: 44 pounds lost (reaching 176 pounds)
• Excellent responder: 55+ pounds lost (reaching 165 pounds or lower)

For detailed results, see our guide on Ozempic weight loss results.

Direct Comparison

Metric	Contrave	Semaglutide
Average % weight loss	5-8%	15%
Pounds lost (220 lb start)	11-18 lbs	33 lbs
Patients losing 5%+	~50%	~86%
Patients losing 10%+	~25-30%	~69%
Patients losing 15%+	<15%	~50%
Trial duration	56 weeks	68 weeks

The difference is approximately two to three times greater weight loss with semaglutide.

Why Such Different Results?

Several factors explain the effectiveness gap:

Mechanism potency: GLP-1 receptor activation produces more profound appetite suppression than the reward pathway modulation that Contrave provides.

Metabolic effects: Semaglutide improves insulin sensitivity and glucose metabolism, contributing additional metabolic benefits that support weight loss.

Sustained effect: Both medications maintain their effects with continued use, but semaglutide’s effect on actual hunger and satiety may be more powerful than Contrave’s effect on cravings.

Food intake reduction: Studies suggest semaglutide produces greater caloric intake reduction than Contrave, explaining the greater weight loss.

Why Would Anyone Choose Contrave?

Given semaglutide’s superior weight loss, why consider Contrave?

Specific eating patterns: Patients whose eating is primarily driven by cravings, emotional triggers, or reward-seeking may find Contrave’s mechanism particularly helpful.

Injection avoidance: Some patients strongly prefer oral medication over injections.

Cost: Contrave may be less expensive depending on insurance coverage.

Mental health co-benefits: Patients with depression may benefit from bupropion’s antidepressant effects alongside weight loss.

Smoking cessation: Patients who also want to quit smoking may benefit from bupropion’s dual action.

Semaglutide contraindications: Patients who cannot take GLP-1 medications may tolerate Contrave.

Side Effect Comparison

The different mechanisms produce distinct side effect profiles.

Contrave Side Effects

Contrave’s side effects primarily reflect its CNS-active components:

Common side effects:

• Nausea (most common, often improves over time)
• Constipation
• Headache
• Dizziness
• Insomnia and sleep disturbances
• Dry mouth
• Vomiting

CNS/mood effects:

• Anxiety or nervousness
• Irritability
• Attention disturbances
• Tremor

Cardiovascular:

• May increase heart rate slightly
• May increase blood pressure
• Not appropriate for uncontrolled hypertension

Serious but rare:

• Seizures (significantly increased risk; contraindicated in seizure disorders)
• Suicidal thoughts (black box warning, particularly in young adults)
• Angle-closure glaucoma
• Hepatotoxicity (rare)
• Severe allergic reactions

Timing: Side effects are often most prominent during the titration period and may improve over weeks. The medication is started at a low dose and increased gradually over 4 weeks to reduce side effects.

Semaglutide Side Effects

Semaglutide’s side effects are primarily gastrointestinal:

Common side effects:

• Nausea (most common, usually improves with time)
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Decreased appetite (intended effect)

Other effects:

• Fatigue (usually temporary)
• Injection site reactions (minor)
• Hair thinning during rapid weight loss (temporary)
• Headache (less common than with Contrave)

Serious but rare:

• Pancreatitis (severe abdominal pain requires immediate attention)
• Gallbladder disease (weight loss increases gallstone risk)
• Thyroid tumors (seen in animal studies; human risk uncertain)

Timing: GI effects are most prominent during dose increases and typically improve over weeks to months. The 4-5 month titration schedule minimizes severity.

Side Effect Comparison Table

Factor	Contrave	Semaglutide
Most common	Nausea, headache, constipation	Nausea, diarrhea
Sleep effects	Insomnia common	Minimal
Mood effects	Possible anxiety, irritability	Minimal
Cardiovascular	May increase HR/BP	May reduce BP
CNS effects	Headache, dizziness common	Uncommon
GI severity	Moderate	Can be significant initially
Seizure risk	Significantly increased	Not increased
Black box warning	Yes (suicidal thoughts)	No

Which Is More Tolerable?

This varies by individual:

Contrave may be more tolerable for: Patients who don’t tolerate GI effects well, who don’t have seizure risk or significant cardiovascular concerns, and who prefer oral medication.

Semaglutide may be more tolerable for: Patients who don’t tolerate CNS side effects (insomnia, anxiety, headache), who have cardiovascular concerns, or who have mood disorders that might be worsened by Contrave.

Neither medication is universally easier to tolerate. Individual response determines which works better for any specific patient.

Cardiovascular Considerations

Cardiovascular effects represent an important differentiator.

Contrave’s Cardiovascular Profile

Contrave has modest cardiovascular concerns:

Known effects:

• May increase resting heart rate by 1-2 bpm on average
• May increase blood pressure in some patients
• Contraindicated in uncontrolled hypertension

Cardiovascular outcome data: The LIGHT trial studied cardiovascular outcomes with Contrave but was terminated early due to data release issues. Available data didn’t show increased cardiovascular events, but the trial wasn’t completed, leaving some uncertainty.

Who should avoid:

• Patients with uncontrolled hypertension
• Those with significant cardiovascular disease (relative caution)
• Patients taking other medications that affect heart rate or blood pressure

Monitoring: Blood pressure and heart rate should be monitored during treatment, particularly during titration.

Semaglutide’s Cardiovascular Profile

Semaglutide has proven cardiovascular benefits:

Demonstrated protection:

• SELECT trial: 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death)
• SUSTAIN-6: 26% reduction in cardiovascular events in diabetic patients

Blood pressure effect:

• Typically reduces systolic blood pressure by 4-6 mmHg
• Modest heart rate increase (2-4 bpm) but offset by overall protection

Appropriate for:

• Patients with established cardiovascular disease
• Those with high cardiovascular risk factors
• Patients who would benefit from cardiovascular protection

Comparison

Factor	Contrave	Semaglutide
Heart rate	May increase slightly	May increase slightly
Blood pressure	May increase	Typically decreases
CV outcome data	Incomplete/uncertain	Proven 20% event reduction
CV disease patients	Use with caution	Appropriate and preferred

For patients with cardiovascular disease or significant risk factors, semaglutide is the clearly preferred option. Contrave isn’t contraindicated in stable cardiovascular disease but lacks the protective benefit semaglutide provides.

Who Each Medication Helps Most

Different patient profiles may suit different medications.

Contrave May Be Better For:

Eating pattern considerations:

• Strong food cravings that drive overeating
• Emotional eating or stress eating patterns
• Feeling addicted to or unable to resist certain foods
• Eating driven by pleasure/reward rather than hunger
• History of binge eating (though diagnosed binge eating disorder requires careful consideration)

Medical considerations:

• Depression (may benefit from bupropion’s antidepressant effect)
• Desire to quit smoking simultaneously
• Inability to tolerate GLP-1 medications
• Preference for oral over injectable medication
• GI conditions that might worsen with semaglutide

Practical considerations:

• Insurance covers Contrave but not semaglutide
• Strong aversion to injections
• Previous success with bupropion for other conditions

Semaglutide Is Likely Better For:

Eating pattern considerations:

• Persistent hunger that makes eating less difficult
• Difficulty feeling satisfied after meals
• Portion control challenges
• Frequent snacking due to not feeling full
• Eating driven by genuine hunger signals

Medical considerations:

• Type 2 diabetes or prediabetes (excellent glucose control)
• Cardiovascular disease or high CV risk
• Fatty liver disease
• Sleep apnea
• Desire for maximum weight loss

Goal considerations:

• Need to lose 15%+ of body weight
• Obesity-related health conditions requiring substantial weight loss
• Previous weight loss attempts have failed to produce adequate results

When Either Might Work

Many patients don’t fit neatly into one category:

• Mixed eating patterns (both cravings and hunger-driven)
• No strong contraindications to either
• Moderate weight loss goals
• Flexibility on administration route
• No clear cardiovascular benefit or concern driving choice

In these cases, either medication might help, and other factors (cost, insurance, personal preference) may determine the choice.

Contraindications Compared

Each medication has specific contraindications that may determine eligibility.

Contrave Contraindications

Absolute contraindications:

• Uncontrolled hypertension
• Seizure disorder or history of seizures
• Conditions that increase seizure risk (eating disorders with purging, alcohol withdrawal, benzodiazepine withdrawal)
• Current or recent use of MAO inhibitors (within 14 days)
• Current opioid use or opioid withdrawal
• Chronic opioid therapy (naltrexone will precipitate withdrawal)
• Pregnancy
• Known allergy to bupropion or naltrexone

Relative contraindications/use with caution:

• History of eating disorders (bulimia, anorexia)
• Controlled hypertension (monitor closely)
• Bipolar disorder (risk of manic episodes)
• Hepatic impairment
• Renal impairment

Medications to avoid:

• Opioid pain medications (naltrexone blocks their effect)
• MAO inhibitors
• Other bupropion products
• Medications that lower seizure threshold

Semaglutide Contraindications

Absolute contraindications:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pregnancy

Relative contraindications/use with caution:

• History of pancreatitis
• Severe gastrointestinal disease
• Diabetic retinopathy (may initially worsen with rapid glucose improvement)

Fewer medication interactions:

• Adjust insulin/sulfonylureas if diabetic (hypoglycemia risk)
• No broad medication contraindications like Contrave has

Contraindication Comparison

Factor	Contrave	Semaglutide
Seizure disorders	Contraindicated	Not contraindicated
Opioid use	Contraindicated	Not contraindicated
Uncontrolled hypertension	Contraindicated	Not contraindicated (may help)
Eating disorders	Contraindicated	Not specifically contraindicated
Thyroid cancer history	Not contraindicated	Contraindicated (MTC)
Pancreatitis history	Not contraindicated	Use with caution
MAO inhibitor use	Contraindicated	Not contraindicated

Contrave has a longer list of contraindications, meaning more patients are ineligible for it than for semaglutide.

Cost Comparison

Cost differences may influence medication accessibility.

Contrave Costs

Contrave is moderately priced:

List price: Approximately $300-400/month

With manufacturer savings: As low as $99/month through manufacturer programs for eligible patients

With insurance: Varies widely; many plans cover it with prior authorization. Typical copay $30-100/month.

Generic availability: Currently unavailable in the US (patent protection), though generic versions exist in some countries.

Semaglutide Costs

Semaglutide is more expensive but has multiple access options:

Brand-name list price:

• Ozempic: ~$1,000/month
• Wegovy: ~$1,350/month

Manufacturer cash-pay programs:

• NovoCare: $349/month for either formulation

Compounded semaglutide:

• TrimRx: $199/month

With insurance: Variable; $25-100/month if covered, but coverage is inconsistent for weight loss indication.

For detailed pricing, see our guide on compounded semaglutide costs.

Cost Comparison Table

Factor	Contrave	Semaglutide
List price	$300-400/month	$1,000-1,350/month
Best cash price	~$99/month (savings program)	$199/month (compounded)
With good insurance	$30-100/month	$25-100/month
Annual cost (cash)	$1,188-4,800	$2,388-4,188
Generic available	No	No (compounded available)

Cost per Outcome

Another way to compare is cost relative to results:

Contrave: At $99-300/month for 12 months ($1,188-3,600) producing 12-18 pounds loss = ~$66-300 per pound lost

Semaglutide: At $199/month for 12 months ($2,388) producing 30-35 pounds loss = ~$68-80 per pound lost

When factoring in greater effectiveness, semaglutide’s cost per pound lost is often comparable to or better than Contrave despite higher monthly cost.

Practical Aspects of Each Medication

Understanding day-to-day use helps set expectations.

Taking Contrave

Administration:

• Oral tablets taken twice daily
• Morning and evening dosing
• Can be taken with or without food
• Swallow whole (don’t crush, chew, or cut)

Titration schedule:

• Week 1: One tablet in the morning
• Week 2: One tablet morning, one evening
• Week 3: Two tablets morning, one evening
• Week 4 and ongoing: Two tablets morning, two evening (full dose)

Daily requirements:

• Remember to take medication twice daily
• Consistent timing helps
• Missed dose: Skip if close to next dose; don’t double up

Lifestyle considerations:

• Avoid excessive alcohol (increases seizure risk)
• May affect sleep if taken too late
• Cannot use opioid pain medications while taking Contrave

Taking Semaglutide

Administration:

• Subcutaneous injection once weekly
• Small needle, minimal discomfort
• Inject into abdomen, thigh, or upper arm
• Rotate injection sites

Titration schedule:

• Weeks 1-4: 0.25mg
• Weeks 5-8: 0.5mg
• Weeks 9-12: 1.0mg
• Weeks 13-16: 1.7mg
• Week 17+: 2.4mg (maintenance)

Weekly requirements:

• Single injection on the same day each week
• Can be any day; consistency helps
• Missed dose: Take within 5 days; if longer, skip and resume schedule

Lifestyle considerations:

• Eat smaller meals to minimize GI effects
• Avoid fatty, greasy foods initially
• Stay hydrated
• No medication restrictions

Comparison of Practicality

Factor	Contrave	Semaglutide
Dosing frequency	Twice daily	Once weekly
Administration	Oral tablets	Subcutaneous injection
Time to full dose	4 weeks	16-20 weeks
Daily burden	Higher (remember twice daily)	Lower (weekly only)
Injection required	No	Yes
Medication interactions	More restrictions	Fewer restrictions

Some patients prefer the simplicity of once-weekly dosing despite the injection; others prefer oral medication despite twice-daily dosing. Neither is universally more convenient.

Mental Health Considerations

Both medications have relevance to mental health, though in different ways.

Contrave and Mental Health

Bupropion’s dual nature:

• Approved antidepressant
• May improve mood in patients with depression
• Can help with smoking cessation

Concerns:

• Black box warning for suicidal thoughts, particularly in young adults (under 24)
• May worsen anxiety in some patients
• Can trigger manic episodes in bipolar disorder
• Insomnia may affect mental health

Who might benefit:

• Patients with comorbid depression who might benefit from bupropion’s mood effects
• Those with emotional eating tied to depression

Who should be cautious:

• Young adults (increased suicidality risk)
• Patients with bipolar disorder
• Those with significant anxiety

Semaglutide and Mental Health

Generally neutral:

• Not designed to affect mood
• No antidepressant or anxiolytic properties
• No black box warning for suicidality

Potential indirect benefits:

• Weight loss may improve mood and self-esteem
• Better physical health may support mental health
• Reduced “food noise” may reduce food-related anxiety

Considerations:

• Some patients report improved mood with weight loss
• Rare reports of mood changes, but not systematic
• No specific concerns for most psychiatric conditions

For Patients with Mental Health Conditions

Depression: Contrave may provide dual benefit but requires careful monitoring. Semaglutide is safe but won’t directly treat depression.

Anxiety: Contrave may worsen anxiety in some patients. Semaglutide is generally neutral.

Bipolar disorder: Contrave poses risk of triggering mania; semaglutide is generally safe.

Eating disorders: Contrave is contraindicated in bulimia/anorexia due to seizure risk from purging. Semaglutide requires careful consideration in any eating disorder due to effects on appetite.

Duration and Long-Term Use

Both medications are approved for long-term use, with different patterns.

Contrave Long-Term Use

Approved duration: Chronic treatment (no maximum specified)

Sustained effectiveness: Weight loss is maintained with continued use in most patients

Tolerance: Unlike stimulants, Contrave doesn’t appear to develop significant tolerance

Stopping: Weight regain is common after discontinuation, as with all weight loss medications

Semaglutide Long-Term Use

Approved duration: Chronic treatment (no maximum specified)

Sustained effectiveness: Weight loss is maintained with continued treatment

Tolerance: No tolerance development; effects persist with ongoing use

Stopping: Research shows approximately two-thirds of lost weight returns within one year of stopping

Long-Term Comparison

Both medications are intended for ongoing use. Neither cures obesity; both manage it. The need for continued treatment to maintain results is similar between medications, though semaglutide’s greater initial weight loss means more weight to potentially regain if stopped.

Making the Decision

How do you choose between these options?

Questions to Consider

About your eating patterns:

• Is your overeating driven more by cravings and reward-seeking, or by persistent hunger?
• Do you struggle with emotional eating or stress eating?
• Do you feel “addicted” to certain foods?
• Is portion control your main challenge?

About your health:

• Do you have cardiovascular disease or significant risk factors?
• Do you have a seizure disorder or increased seizure risk?
• Do you use opioid medications for pain?
• Do you have depression that might benefit from bupropion?

About practical factors:

• Do you strongly prefer pills over injections, or vice versa?
• Can you remember to take medication twice daily, or is weekly dosing easier?
• What does your insurance cover?
• What can you afford long-term?

About your goals:

• How much weight do you need to lose?
• How quickly do you want to see results?
• Are you seeking maximum weight loss or modest improvement?

A Decision Framework

Lean toward Contrave if:

• Eating is primarily driven by cravings, reward-seeking, or emotional triggers
• You have depression that might benefit from bupropion
• You strongly prefer oral medication
• You cannot take GLP-1 medications
• Insurance covers Contrave but not semaglutide
• Weight loss goals are more modest (5-10%)

Lean toward semaglutide if:

• You want maximum weight loss (15%+)
• You have cardiovascular disease or high risk
• You have diabetes or prediabetes
• Your eating is driven by persistent hunger and difficulty feeling full
• You prefer weekly over daily medication
• You can afford it or have coverage

Either might work if:

• You have mixed eating patterns
• No clear medical factor driving choice
• Both are accessible and affordable
• Moderate weight loss would meet your goals

Discuss With Your Provider

Bring these considerations to your healthcare provider:

• Your specific eating patterns and challenges
• Your complete medical history and current medications
• Your weight loss goals
• Your insurance coverage and budget
• Your preferences about administration

Your provider can help weigh these factors against your specific health profile.

Frequently Asked Questions

Which medication produces more weight loss, Contrave or Ozempic?

Ozempic (semaglutide) produces significantly more weight loss. Clinical trials show semaglutide produces approximately 15% average body weight loss, while Contrave produces 5-8% on average. For a 220-pound person, this translates to roughly 33 pounds lost with semaglutide versus 11-18 pounds with Contrave. About 69% of semaglutide users lose at least 10% of body weight, compared to approximately 25-30% of Contrave users. If maximum weight loss is your primary goal, semaglutide is substantially more effective.

Does Contrave help with emotional eating better than Ozempic?

Contrave’s mechanism may be more specifically suited to emotional eating and food cravings. It works on brain reward pathways, reducing the pleasure and reward derived from eating, which may particularly help people who eat for emotional comfort or who feel unable to resist cravings. Semaglutide reduces overall hunger and increases satiety but doesn’t specifically target reward pathways. That said, both medications reduce food intake and can help with overeating regardless of the underlying driver. Clinical trials don’t directly compare their effects on emotional eating specifically.

Can I take Contrave if I take pain medication?

This depends on the type of pain medication. Contrave contains naltrexone, an opioid antagonist that blocks opioid receptors. If you take opioid pain medications (like hydrocodone, oxycodone, morphine, or tramadol), Contrave will block their pain-relieving effects. If you’re dependent on opioids, naltrexone can precipitate withdrawal. Therefore, Contrave is contraindicated if you regularly use opioid medications or are in opioid withdrawal. Non-opioid pain medications (NSAIDs, acetaminophen) are fine to use with Contrave. Discuss your pain management with your provider before considering Contrave.

Is Contrave safer than Ozempic?

Neither medication is universally “safer.” They have different safety profiles. Contrave has more contraindications (seizure disorders, opioid use, uncontrolled hypertension, eating disorders) and carries a black box warning for suicidal thoughts in young adults. It may also increase heart rate and blood pressure. Semaglutide has fewer contraindications (mainly personal/family history of medullary thyroid carcinoma) and has proven cardiovascular protection. Semaglutide carries risks of pancreatitis and gallbladder disease. Which is “safer” depends entirely on your specific health profile and risk factors.

Why does Contrave contain a drug for addiction?

Contrave contains naltrexone, which is used to treat alcohol and opioid addiction, because it blocks opioid receptors involved in reward and pleasure responses. Food, particularly highly palatable food, activates some of these same reward pathways. By blocking opioid receptors, naltrexone reduces the rewarding and pleasurable aspects of eating, potentially helping people who struggle with food cravings or feel “addicted” to certain foods. Combined with bupropion’s appetite effects, this creates a medication that addresses both hunger and the reward value of eating.

Does insurance cover Contrave or Ozempic for weight loss?

Coverage varies significantly by plan for both medications. Contrave is FDA-approved specifically for weight loss, which may help coverage, but many plans exclude or restrict weight loss medications. Ozempic is approved for diabetes (not weight loss), while Wegovy (same medication) is approved for weight loss. Plans may cover Ozempic for diabetes but not for weight loss alone. Prior authorization is typically required for both. Many patients end up paying out of pocket regardless of which medication they choose. Check your specific plan’s formulary and contact them directly to understand your coverage.

Can I switch from Contrave to Ozempic if it’s not working?

Yes, you can switch medications if one isn’t producing adequate results. If Contrave isn’t providing sufficient weight loss after several months of use, transitioning to semaglutide is straightforward. You would stop Contrave and begin semaglutide’s standard titration schedule. There’s no required waiting period between medications. Be aware that semaglutide takes 4-5 months to reach full dose, so results won’t be immediate. Discuss switching with your provider to ensure it’s appropriate for your situation.

Do both medications require a prescription?

Yes, both Contrave and semaglutide (Ozempic, Wegovy) are prescription medications requiring a healthcare provider’s authorization. Neither is available over the counter. Contrave is not a controlled substance but does require a prescription. Semaglutide is also not a controlled substance. Both can be prescribed by primary care physicians, endocrinologists, obesity medicine specialists, or through telehealth platforms like TrimRx. You’ll need a consultation with a provider to determine eligibility and obtain a prescription.

Which medication is better for people with diabetes?

Semaglutide is substantially better for patients with Type 2 diabetes. It produces greater weight loss (approximately 10-12% even in diabetic patients, who typically lose less than non-diabetics), provides excellent blood sugar control (HbA1c reductions of 1.0-1.8 percentage points), and has proven cardiovascular protection (especially important since diabetes increases cardiovascular risk). Ozempic is FDA-approved specifically for Type 2 diabetes. Contrave has minimal blood sugar effects beyond what weight loss itself provides and lacks cardiovascular protection. For diabetic patients, semaglutide is the clear choice in most cases.

How long does it take to see results with each medication?

Contrave: Weight loss typically begins within the first month after reaching full dose (week 4). Meaningful results (5%+ loss) usually occur within 12-16 weeks. If you haven’t lost at least 5% by week 12 at full dose, the medication may not be effective for you. Semaglutide: Appetite changes often begin within weeks, but significant weight loss takes longer due to the gradual titration. Most weight loss occurs between months 4-12 when at maintenance doses. The full titration takes about 4-5 months, so results develop more gradually than with Contrave but ultimately exceed what Contrave achieves.

Can Contrave help with quitting smoking?

Yes, Contrave contains bupropion, which is the active ingredient in Zyban, a medication approved for smoking cessation. If you’re trying to lose weight and quit smoking simultaneously, Contrave might address both goals. However, you shouldn’t take Contrave if you’re already taking another bupropion product (Wellbutrin, Zyban), as this would result in excessive bupropion dosing and increased seizure risk. If smoking cessation is a goal alongside weight loss, discuss with your provider whether Contrave might serve dual purposes for you.

The Bottom Line

Contrave and Ozempic represent fundamentally different approaches to weight loss medication. Semaglutide produces roughly twice to three times more weight loss and offers cardiovascular protection, making it the more effective choice for most patients seeking significant, sustained weight loss. Contrave’s mechanism targeting reward pathways may make it particularly helpful for patients whose eating is driven by cravings and emotional factors, and it offers the convenience of oral medication.

For patients without cardiovascular concerns who specifically struggle with food cravings and reward-driven eating, who prefer oral medication, or who have better insurance coverage for Contrave, it remains a reasonable option. For most patients seeking maximum weight loss, particularly those with cardiovascular disease, diabetes, or substantial weight to lose, semaglutide is the superior choice.

Discuss your specific situation, eating patterns, health conditions, and practical constraints with your healthcare provider to determine which medication is right for you.

Ready to explore semaglutide treatment? TrimRx offers consultations with licensed providers who can evaluate your eligibility and prescribe compounded semaglutide at $199/month for qualifying patients.